Aethlon Medical Inc AEMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:54 AM EDT
1.05quote price arrow up+0.02 (+2.15%)
Volume
16,357
52 week range
0.88 - 12.49
Loading...
  • Open1.03
  • Day High1.06
  • Day Low1.00
  • Prev Close1.03
  • 52 Week High12.49
  • 52 Week High Date06/09/21
  • 52 Week Low0.88
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap16.19M
  • Shares Out15.41M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change-43.01

KEY STATS

  • Open1.03
  • Day High1.06
  • Day Low1.00
  • Prev Close1.03
  • 52 Week High12.49
  • 52 Week High Date06/09/21
  • 52 Week Low0.88
  • 52 Week Low Date05/12/22
  • Market Cap16.19M
  • Shares Out15.41M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change-43.01

RATIOS/PROFITABILITY

  • EPS (TTM)-0.61
  • P/E (TTM)-1.71
  • Fwd P/E (NTM)-1.44
  • EBITDA (TTM)-8.79M
  • ROE (TTM)-55.12%
  • Revenue (TTM)320,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,822.72%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date06/24/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aethlon Medical Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Aethlon Medical, Inc. (Aethlon) is a medical technology company, which is focused on developing products to diagnose and treat life and organ threatening diseases. The Company operates through two segments: Aethlon and ESI. The Aethlon segment represents its therapeutic business activities. The ESI segment represents its diagnostic business activities. The Company's product, Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and...
Edward Broenniman
Independent Chairman of the Board
Charles Fisher Jr.
Chief Executive Officer, Director
James Frakes
Chief Financial Officer, Senior Vice President - Finance, Secretary
Address
11555 SORRENTO VALLEY ROAD, SUITE 203
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
MOTS
Motus GI Holdings Inc
0.2675+0.0053+2.02%
RSLS
ReShape Lifesciences Inc
0.8078+0.0218+2.77%
TLIS
Talis Biomedical Corp
1.01+0.03+3.05%
INVO
INVO Bioscience Inc
1.47+0.06+3.89%
CHEK
Check Cap Ltd
0.3325-0.0269-7.4847%